… Michael J. Fox Foundation (MJFF) announces 127 grants that total $86 million awarded in December 2024 and January … environmental exposures on stem cells, helping illuminate how those exposures might drive changes in the brain, … those associated with PD.  One project chosen from the RFA comes from Professor Lezanne Ooi’s research at University of …

… Disease Objective/Rationale :  We are attempting to perfect gene therapy using glial cell line-derived … engineering the ability to turn off GDNF delivery using the common antibiotic, doxycycline. There are some significant … about 20% of the antibiotic blood level. Then, when we know how much doxycycline to administer, we will determine …

… J. Fox Foundation (MJFF) is sharing opportunities for our community to advocate with Congress for policies critical to people … advocacy. Congress wants to hear what you want them to do, how they can do it, how this impacts their local district …

… "I come to you this evening to tell you that I think we're at a very … individuals who work to further public policies in support of the Parkinson's disease (PD) community. Dr. Collins is the director of the National …

… signs funding bill including $8.4 million over four years  to accelerate data collection effort toward a Parkinson’s … J. Fox Foundation for Parkinson’s Research (MJFF) today commended California Governor Gavin Newsom for signing the … like this registry can have a direct and lasting impact on how the research community does its work — data collection …

… are pathological hallmarks of Parkinson’s disease.  Compelling genetic evidence has also implicated GCase in … Ambroxol is an existing drug that can “chaperone” GCase to its mature form where it no longer promotes pathological deposit formation.  We intend to test whether ambroxol can ameliorate Parkinson’s …